Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

Journal of Clinical Psychopharmacology

Volumn 16, Issue 5, 1996, Pages 403-409

  Pollmächer, Thomas ^a   Hinze Selch, Dunja ^a   Mullington, Janet ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CYTOKINE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; IMMUNOLOGY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CYTOKINES; FEMALE; FEVER; HUMANS; MALE; RECEPTORS, CYTOKINE; SCHIZOPHRENIA;

EID: 0029846298     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199610000-00011     Document Type: Article

References (47)

1. Baldessarini RJ, Frankenburg FR. Clozapine - a novel antipsychotic agent. N Engl J Med 1991;324:746-54.
2. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis. N Engl J Med 1993; 329:162-7.
3. Blum A, Mauruschat W. Temperaturanstiege und Bluteiweißveränderungen unter der Therapie mit Neuroleptika - unter besonderer Berücksichtigung des neuartigen Dibenzodiazepin-Derivates Clozapin. Pharmakopsychiatrie 1972;5:165-69.
4. Gaertner JH, Fischer E, Hoss J. Side effects of clozapine. Psychopharmacology 1989;99[suppl]:S97-S100.
5. Maes M, Meltzer HY, Bosmans E. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 1994;89:346-51.
6. Pollmächer T, Hinze-Selch D, Mullington J, Holsboer F. Clozapine-induced increase in plasma soluble interleukin-2 receptors. Arch Gen Psychiatry 1995;52:877-88.
7. Robb RJ, Kutny RM. Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble tac protein. J Immunol 1987;139: 855-62.
8. Rubin LA, Nelson DL. The soluble interleukin-2 receptor. Biology, function, and clinical application. Ann Intern Med 1990;113: 619-27.
9. Crispino S, Lissoni P, Ardizzola A, Rovelli F, Perego MS, Grassi MG, Barni S, Pittalis S, Tancini G. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients. J Biol Regul Homeost Agents 1993;7:92-4.
10. Parrillo JP. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
11. Kluger MJ. Fever role of pyrogens and cryogens. Physiol Rev 1991;71:93-117.
12. Gudewill S, Pollmächer T, Vedder H, Schreiber W, Fassbender K, Holsboer F. Nocturnal plasma levels of cytokines in healthy men. Eur Arch Psychiatry Clin Neurosci 1992;242:53-6.
13. Pollmächer T, Schreiber W, Gudewill S, Vedder H, Fassbender K, Wiedemann K, Trachsel L, Galanos C, Holsboer F. Influence of endotoxin on nocturnal sleep in humans. Am J Physiol 1993;264: R1077-83.
14. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994;8:1314-25.
15. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA. Production of interleukin-1 receptor antagonist during experimental endotoxaemia. Lancet 1991;338: 1423-4.
16. Arzt E, Sauer J, Pollmächer T, Labeur M, Holsboer F, Reul JMHM, Stalla GK. Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology 1994;134:672-7.
17. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JWM, Endres S, Lonnemann G, Corsetti J, Chernow B, Wilmore DW, Wolff SM, Burke JF, Dinarello CA. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:79-34.
18. Kuhns DB, Alvord WG, Gallin JI. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995;171: 145-52.
19. van der Poll T, Lowry SF. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 1995;3:1-12.
20. Diez-Ruis A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1-8.
21. Wei S, Blanchard DK, Liu JH, Leonard WJ, Djeu JY. Activation of tumor necrosis factor-α production from human neutrophils by IL-2 via IL-2-Rβ. J Immunol 1993;150:1979-87.
22. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990;172:599-607.
23. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987;165:1581-94.
24. Djeu JY, Serbousek D, Blanchard DK. Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 1990;76: 1405-9.
25. Zola H, Flego L, Weedon H. Expression of membrane receptor for tumor necrosis factor on human blood lymphocytes. Immunol Cell Biol 1993;71:281-8.
26. Cope AP, Aderka D, Wallach D, Kahan M, Chu NR, Brennan FM, Feldmann M. Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF. Immunology 1995;84:21-30.
27. Sperner-Unterweger B, Gaggl S, Fleischhacker WW, Barnas C, Herold M, Geissler D. Effects of clozapine on hematopoiesis and the cytokine system. Biol Psychiatry 1993;34:536-43.
28. Steward WP. Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet 1993;342:153-7.
29. Sisson SD, Dinarello CA. Production of interleukin-1α, interleukin-1β and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood 1988;72:1368-74.
30. Horii Y, Muraguchi A, Suematsu S, Matsuda T, Yoshizaki K, Hirano T, Kishimoto T. Regulation of BSF-2/IL-6 production by human mononuclear cells. J Immunol 1988;141:1529-35.
31. Cicco NA, Lindemann A, Content J, Vandenbussche P, Lübbert M, Gauss J, Mertelsmann R, Herrmann F. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha. Blood 1990;75:2049-52.
32. Bauer J, Herrmann F. Interleukin-6 in clinical medicine. Ann Hematol 1991;62:203-10.
33. Rapaport MH, Doran AR, Nelson DL, McAllister C, Magliozzi JR, Paul SM. Haloperidol and soluble interleukin-2 receptors. Biol Psychiatry 1991;30:1063-5.
34. Bertini R, Garattini S, Delgado R, Ghezzi P. Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology 1993; 79:217-9.
35. Mengozzi M, Fantuzzi G, Faggioni R, Marchant A, Goldman M, Orencole S, Clark BD, Sironi M, Benigni F, Ghezzi P. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology 1994;82: 207-10.
36. Schleuning M, Brumme V, Wilmanns W. Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives. Naunyn-Schmiedebergs Arch Pharmacol 1994;350:100-3.
37. 51Cr release assay of clozapine-induced cytotoxicity: evidence for immunogenic mechanism. J Clin Psychiatry 1994;55:9[suppl B]143-8.
38. Uetrecht JP. Metabolism of clozapine by neutrophils. Drug Saf 1992;7[suppl 1]:51-6.
39. Uetrecht JP. Drug metabolism by leukocytes, its role in drug-induced lupus and other idiosyncratic drug reactions. Crit Rev Toxicol 1990;20:213-35.
40. van der Poll T, van Deventer SJH, Hack EC, Wolbink GJ, Aarden LA, Büller HR, ten Cate JW. Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood 1992;79:693-8.
41. Lantz M, Björnberg F, Olsson I, Richter J. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J Immunol 1994;152:1362-9.
42. Smith RS. A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med Hypotheses 1992;39:248-57.
43. Rapaport MH, McAllister CG, Pickar D. Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch Gen Psychiatry 1989;46:291-2.
44. Ganguli R, Rabin BS. Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects. Arch Gen Psychiatry 1989;46:292.
45. Ganguli R, Yang Z, Shurin G, Chengappa KNR, Brar JS, Gubbi AV, Rabin BS. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 1994; 51:1-10.
46. Rapaport MH, Lohr JB. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand 1994;90:311-5.
47. Xu HM, Wei J, Hemmings GP. Changes of plasma concentrations of interleukin-1α and interleukin-6 with neuroleptic treatment for schizophrenia. Br J Psychiatry 1994;164:251-3.